Enanta Pharmaceuticals CEO Jay Luly Announces Retirement by February 1, 2027

Bitget2026/10/28 11:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Enanta Pharmaceuticals President and CEO Jay R. Luly, 70, will retire by February 1, 2027, following 23 years of leadership.
Luly will serve as a strategic advisor for the remainder of 2027 to support the transition.
The board has launched a search for his successor, considering internal and external candidates.
Tara L. Kieffer, most recently chief product strategy officer, was appointed to the newly created chief operating officer role.
Kieffer joined Enanta in 2020 following a 16-year career at Vertex Pharmaceuticals spanning research, clinical development and business functions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enanta Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261028569198) on October 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Enanta Pharmaceuticals CEO Jay Luly Announces Retirement by February 1, 2027

You may also like

Crypto prices